Preamble
The information set forth in the Schedule below is the outcome of the consideration by the National Drugs and Poisons Schedule Committee at its meeting on 19-21 November 1996 of the scheduling proposals notified in the Commonwealth of Australia Gazette of 9 October 1996 (Part A) as well as other scheduling proposals (Part B and Part C).
...
...
c) 4-HYDROXYBUTANOIC ACID - Schedule 9 classification
Outcome
Schedule 9 - Amendment
4-HYDROXYBUTANOIC ACID - amend entry to read:
4-HYDROXYBUTANOIC ACID and its salts.
The above amendment clarifies that it is not the intent of the Committee to include all derivatives of 4-hydroxybutanoic acid under the Schedule 9 entry. Derivatives are to be considered separately, and
the following derivative was given a specific Schedule entry:
Schedule 9 - New entry
GAMMA BUTYROLACTONE.
from:
http://www.health.gov.au/tga/docs/html/legis/g970108.htm